People · Operator
Named in public records as an officer, director or promoter · active 2013–2018 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Paragon Bioservices, Inc. | — | Biotechnology | Series A | $22.9M | $180.8M | 2017 |
| Rvue Holdings, Inc. | — | Other Technology | Seed | $10.6M | $9.2M | 2013 |
Robert Roche at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Roche on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick O'Donnell | 1 | 6 |
| Kapila Ratnam | 1 | 5 |
| Richard Sullivan | 1 | 4 |
| Thomas Harrison | 1 | 3 |
| Jay Wilson | 1 | 3 |
| Peter Buzy | 1 | 2 |
| CHRISTOPHER KERSEY | 1 | 2 |
| DONALD HUGHES | 1 | 2 |
| Michael Mullarkey | 1 | 2 |
| MARK PACCHINI | 1 | 1 |
| Robert Chimbel | 1 | 1 |
| Dawn Rahicki | 1 | 1 |
| Peter Emerson | 1 | 1 |
| Jason Kates | 1 | 1 |
| Marco Chacon | 1 | 1 |
| Patrick Hervy | 1 | 1 |
| David Loppert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.